We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+11.98%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.25B
AUM Growth
+$34.5M
Cap. Flow
-$87.4M
Cap. Flow %
-6.99%
Top 10 Hldgs %
45.53%
Holding
136
New
1
Increased
21
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.85M
2
CVS icon
CVS Health
CVS
+$228K
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$184K
4
SNPS icon
Synopsys
SNPS
+$29.8K
5
MSFT icon
Microsoft
MSFT
+$28.8K

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.32M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.86M
3
KLAC icon
KLA
KLAC
+$5.4M
4
LOW icon
Lowe's Companies
LOW
+$4.44M
5
SCHW
Charles Schwab
SCHW
+$4.37M

Sector Composition

Rank Sector Weight
1 Technology 45.76%
2 Healthcare 15.36%
3 Communication Services 14.06%
4 Consumer Discretionary 11.65%
5 Financials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
51
State Street
STT
$50.9B
$4.34M 0.35%
59,373
-33,947
-36% -$2.44M
CRM icon
52
Salesforce
CRM
$134B
$4.04M 0.32%
19,104
-9,825
-34% -$2.01M
CAH icon
53
Cardinal Health
CAH
$53.4B
$3.7M 0.3%
39,173
COHU icon
54
Cohu
COHU
$2.39B
$3.46M 0.28%
83,183
-8,020
-9% -$296K
AEIS icon
55
Advanced Energy
AEIS
$12.2B
$3.43M 0.27%
30,745
-2,337
-7% -$223K
DGX icon
56
Quest Diagnostics
DGX
$25.1B
$3.16M 0.25%
22,478
-5,110
-19% -$704K
COR icon
57
Cencora
COR
$60.3B
$3.16M 0.25%
16,404
AIT icon
58
Applied Industrial Technologies
AIT
$12.8B
$3.01M 0.24%
20,805
-988
-5% -$132K
ENSG icon
59
The Ensign Group
ENSG
$10.1B
$2.96M 0.24%
31,050
-2,002
-6% -$189K
AMBA icon
60
Ambarella
AMBA
$2.99B
$2.95M 0.24%
35,267
-4,691
-12% -$343K
PRFT
61
DELISTED
Perficient Inc
PRFT
$2.85M 0.23%
34,148
PYPL icon
62
PayPal
PYPL
$49.5B
$2.7M 0.22%
40,401
-12,862
-24% -$877K
CRUS icon
63
Cirrus Logic
CRUS
$6.74B
$2.68M 0.21%
33,141
-2,689
-8% -$222K
MRK icon
64
Merck
MRK
$324B
$2.67M 0.21%
23,150
-15
-0.1% -$1.7K
ATVI
65
DELISTED
Activision Blizzard
ATVI
$2.62M 0.21%
31,087
VRTX icon
66
Vertex Pharmaceuticals
VRTX
$121B
$2.62M 0.21%
7,434
-582
-7% -$196K
MDT icon
67
Medtronic
MDT
$107B
$2.45M 0.2%
27,821
-4
-0% -$344
NDSN icon
68
Nordson
NDSN
$16.5B
$2.45M 0.2%
9,854
SIMO icon
69
Silicon Motion
SIMO
$9.19B
$2.43M 0.19%
33,810
-2,723
-7% -$174K
SEDG icon
70
SolarEdge
SEDG
$2.59B
$2.39M 0.19%
8,897
EXEL icon
71
Exelixis
EXEL
$13.9B
$2.37M 0.19%
123,896
PEP icon
72
PepsiCo
PEP
$186B
$2.29M 0.18%
12,380
-1,560
-11% -$291K
NXGN
73
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.28M 0.18%
140,328
+746
+0.5% +$12.4K
LRCX icon
74
Lam Research
LRCX
$382B
$2.25M 0.18%
35,000
UTHR icon
75
United Therapeutics
UTHR
$26.3B
$2.08M 0.17%
9,421

Similar funds

Oak Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Oak Associates held 136 positions worth $1.25B, up 2.8% from $1.22B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $87.4M in Q2 2023, closing 5 positions and reducing 59 holdings. Its most notable exit was Ubiquiti, an estimated $1.54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Incyte worth $1.72M.

  • Oak Associates's largest Q2 2023 buy was Incyte: 27,651 shares worth $1.72M.
  • Oak Associates added most to CVS Health in Q2 2023, an estimated $228K increase.
  • Oak Associates's biggest Q2 2023 reduction was Amazon, cutting an estimated $6.32M.
  • Oak Associates fully exited Ubiquiti in Q2 2023, selling an estimated $1.54M.
  • Oak Associates's ten largest holdings make up 46% of its $1.25B portfolio in Q2 2023.
  • Oak Associates opened 1 new position and closed 5 in Q2 2023.
  • Oak Associates's portfolio value rose 2.8% quarter-over-quarter to $1.25B.

Based on Oak Associates's 13F filing for Q2 2023, filed 11 Aug 2023.